- Home
- ARWR vs ESAB Comparison
ARWR vs ESAB Comparison
Compare ARWR & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | ESAB |
|---|---|---|
| Founded | 2003 | 1904 |
| Country | United States | United States |
| Employees | N/A | 10300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 5.7B |
| IPO Year | 2009 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ARWR | ESAB |
|---|---|---|
| Price | $77.64 | $92.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | $83.40 | ★ $138.56 |
| AVG Volume (30 Days) | ★ 1.5M | 473.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | $16,142,321.00 | ★ $2,842,555,000.00 |
| Revenue This Year | N/A | $6.21 |
| Revenue Next Year | N/A | $5.33 |
| P/E Ratio | ★ N/A | $119.60 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $14.30 | $83.17 |
| 52 Week High | $82.26 | $137.42 |
Technical Indicators
Market Signals| Indicator | ARWR | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 56.42 | 45.38 |
| Support Level | $70.49 | $89.41 |
| Resistance Level | $82.26 | $118.33 |
| Average True Range (ATR) | 3.69 | 3.76 |
| MACD | -0.19 | 0.44 |
| Stochastic Oscillator | 66.36 | 51.54 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.8 billion in revenue in 2025.